EXOZ vs MSCI · $83.5M cap vs P/E 37, rev $1.72B
eXoZymes, Inc. (EXOZ) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
eXoZymes, Inc. (EXOZ) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
EXOZ does not have a complete income-statement cache yet.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
EXOZ currently screens at market cap $83.5M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the EXOZ and MSCI stock pages for the full models.
Not investment advice.